EPA OKs first living pest-control mosquito for use in United States | Science News

Support Science Journalism

Science News is a nonprofit.

Support us by subscribing now.

Science Ticker

A roundup of research
and breaking news

Science News Staff
Science Ticker

EPA OKs first living pest-control mosquito for use in United States

Asian tiger mosquitoes made bad dad by Wolbachia bacteria can suppress local populations

Asian tiger mosquito

WATCH OUT The Asian tiger mosquito (shown) is an unloved invader in much of the world, but now a bad-dad version is about to be commercially launched as a living tool to control populations of the pests.

Sponsor Message

In a big step toward catching up with the rest of the world, the United States cleared the way for using mosquitoes as a commercial pest control for the first time.

The U.S. Environmental Protection Agency has approved using a strain of male Asian tiger mosquitoes (Aedes albopictus) as a biopesticide in the District of Columbia and 20 states, including California and New York. Kentucky-based MosquitoMate was granted the right to sell these mosquitoes, called ZAP Males, for the next five years, the agency announced November 7.

These male mosquitoes are not genetically modified. Instead they carry a strain of Wolbachia bacteria that turns them into saboteur dads. When they mate with wild females not carrying the strain, the offspring will die and the population should dwindle. Males don’t bite, so releasing them should not add extra vexation.

Releases of Wolbachia-bearing mosquitoes for pest control already go on in other countries, such as Brazil, although with a different bacterial strain and a different strategy.

This same company has also been testing the effectiveness of a different mosquito species, Aedes aegypti, also carrying bad-dad Wolbachia, near Key West, Fla. (These mosquitoes are not commercially available.) The tests “ended a bit early due to [Hurricane] Irma,” says Stephen Dobson of MosquitoMate, “but we think that we have some good data despite this complication.”

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content